Clinical impact of immediate residual stenosis on clinical outcomes after deploying everolimus-eluting stent and biolimus-eluting stents: insights from a pooled analysis of RESET and NEXT trial.

26 August 2017 (00:00 - 00:00)

Organised by:

About the speaker

Mr Hiroki Watanabe

Japan Red Cross Society Wakayama Medical Center, Wakayama (Japan)

11 More presentations in this session

Presentation thumbnail

Impact of the J-CTO score on long-term target lesion revascularization rate after native chronic total coronary occlusion angioplasty

Doctor M. Abe (Kyoto, JP)

Presentation thumbnail

Contribution of post-stent irregular protrusion to in-stent neoatheroscrelosis after second-generation drug-eluting stent implantation. - Optical coherence tomography study-

Doctor Y. Sanuki (Kitakyusyu, JP)

Abstract Slides

Presentation thumbnail

Impact of chronic kidney disease on stent strut coverage and neointimal tissue characteristics as assessed by optical coherence tomography

Miss Y. Wang (Harbin, CN)

Abstract Slides

Presentation thumbnail

Predictors of target lesion revascularization after paclitaxel-coated balloon treatment of in-stent restenosis: a real-world single center registry.

Doctor I. Bossi (Milano, IT)

Abstract Slides

Presentation thumbnail

Five-year outcomes after first- or second-generation drug-eluting stent implantation in all-comer patients undergoing percutaneous coronary intervention

Doctor H. Yano (Odawara, JP)

Abstract Slides

Access the full session

Session thumbnail

Poster session 1 - PCI - Restenosis

The Event

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources